UGGT2-TRPC4 Fusion FISH Probe
The UGGT2-TRPC4 Fusion FISH Probe is used to confirm a fusion of the UGGT2 and TRPC4 genes. The fusion of the UGGT2 and TRPC4 genes has been associated with Prostate Adenocarcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| UGGT2-TRPC4-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| UGGT2-TRPC4-20-RERE | 20 (40 μL) | 200 μL |
|
|
| UGGT2-TRPC4-20-REOR | 20 (40 μL) | 200 μL |
|
|
| UGGT2-TRPC4-20-REGO | 20 (40 μL) | 200 μL |
|
|
| UGGT2-TRPC4-20-REGR | 20 (40 μL) | 200 μL |
|
|
| UGGT2-TRPC4-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| UGGT2-TRPC4-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| UGGT2-TRPC4-20-OROR | 20 (40 μL) | 200 μL |
|
|
| UGGT2-TRPC4-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| UGGT2-TRPC4-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| UGGT2-TRPC4-20-GORE | 20 (40 μL) | 200 μL |
|
|
| UGGT2-TRPC4-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| UGGT2-TRPC4-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| UGGT2-TRPC4-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| UGGT2-TRPC4-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| UGGT2-TRPC4-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| UGGT2-TRPC4-20-GROR | 20 (40 μL) | 200 μL |
|
|
| UGGT2-TRPC4-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| UGGT2-TRPC4-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| UGGT2-TRPC4-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| UGGT2-TRPC4-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| UGGT2-TRPC4-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| UGGT2-TRPC4-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| UGGT2-TRPC4-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| UGGT2-TRPC4-20-AQAQ | 20 (40 μL) | 200 μL |
|
TRPC4 Gene Summary
This gene encodes a member of the canonical subfamily of transient receptor potential cation channels. The encoded protein forms a non-selective calcium-permeable cation channel that is activated by Gq-coupled receptors and tyrosine kinases, and plays a role in multiple processes including endothelial permeability, vasodilation, neurotransmitter release and cell proliferation. Single nucleotide polymorphisms in this gene may be associated with generalized epilepsy with photosensitivity. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Aug 2011]
Gene Name: Transient Receptor Potential Cation Channel Subfamily C Member 4
Chromosome: CHR13: 38210772 -38443939
Locus: 13q13.3
UGGT2 Gene Summary
UDP-glucose:glycoprotein glucosyltransferase (UGT) is a soluble protein of the endoplasmic reticulum (ER) that selectively reglucosylates unfolded glycoproteins, thus providing quality control for protein transport out of the ER.[supplied by OMIM, Oct 2009]
Gene Name: UDP-glucose Glycoprotein Glucosyltransferase 2
Chromosome: CHR13: 96453835 -96705736
Locus: 13q32.1
Gene Diseases
The UGGT2 TRPC4 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Prostate Adenocarcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|